Health Care: Drugs

Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)

$4.53 -0.06 | -1.31%
06/18/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 4.07M 5.66M 42.88M 9.51M
Cost of Sales 0.00 0.00 0.00 -4.98M
Gross Operating Profit 4.07M 5.66M 42.88M 14.49M
Selling, General, and Administrative Expenses 11.09M 11.77M 14.00M 15.41M
Research & Development 21.85M 28.26M 33.53M 39.78M
Operating Income before D & A (EBITDA) -28.87M -34.37M -4.65M -40.69M
Depreciation & Amortization 4.78M 5.24M 5.04M 4.98M
Interest Income 420.00K 26.00K 35.00K 92.00K
Other Income - Net 1.90M -4.00M 4.77M -69.55M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -31.34M -43.58M -4.88M -117.16M
Interest Expense 1.43M 2.19M 1.63M 467.00K
Pre-Tax Income -32.76M -45.77M -6.52M -117.63M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 -13.99M
Net Income From Continuing Operations -27.98M -40.53M -1.48M -103.64M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -27.98M -40.53M -1.48M -103.64M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -27.98M -40.53M -1.48M -103.64M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -27.98M -40.53M -1.48M -101.61M
Preferred Dividends
Net Income Available To Common -27.98M -40.53M -1.48M -103.64M
Basic EPS from Continuing Ops. -2.24 -6.00 -0.30 -26.80
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.24 -6.00 -0.30 -26.80
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.24 -6.00 -0.30 -26.80
Basic Normalized Net Income/Share -2.24 -6.00 -0.30 -26.27
EPS fr Continuing Ops. -2.24 -6.00 -0.30 -26.80
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.24 -6.00 -0.30 -26.80
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.24 -6.00 -0.30 -26.80
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -2.24 -6.00 -0.30 -26.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALXA

View All

Latest ALXA Headlines from TheStreet

More Financial News for ALXA

Press Releases for ALXA

See All Press Releases

Partner Headlines for ALXA

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter